Expression of NFATc1 is decreased in <i>Tcirg1</i>-knockdown osteoclasts. by Dongyan Zhang (640677)

CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

“…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”

Ena/VASP Mislocalization Decreases the Prevalence of Fast, Persistent-Moving Smooth Cells by Catherine I Lacayo (34086)

Stx16-depleted MDCK monolayer show decreased transepithelial resistance (TER). by Jae-Joon Jung (139625)

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)

Apicoplast inhibitors decrease global parasite prenylation in the second IDC after treatment. by Kit Kennedy (4915510)

miR-181b overexpression decreases cell mitochondrial membrane potential. by Samira Ghorbani (3843895)

The apparent Ca²⁺ affinity of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

“…The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca²⁺ affinity of neurotransmitter release.…”

Decreased cell proliferation rate and increased apoptosis in hICD-expressing cells. by Shixuan Wang (136189)

Inhibition of SNAI2 expression decreases the sensitivity to chemotherapy drugs of HCC cells. by Xin-Yu Zhao (3228756)

Leptin administration decreases microglial/macrophage activation but has no effect on astroglial reactivity. by Carmen María Fernández-Martos (5649061)

Deletion of STX1B decreases frequency of mEPSCs and mIPSCs. by Tatsuya Mishima (529071)

TL decreases cell viability in malignant cells dependent of p53 status. by Ajay Kumar (192967)

CDK16 protein level is decreased in <i>Ccnyl1</i>-/- testis. by Zhenzhen Zi (787008)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation. by Juanita K. Hodax (6848540)

Cellular proliferation is decreased in LV-shRNA-ADAMTS-1 transduced vessels. by Evelyn C. Nieves Torres (551495)

“…By day 7, there is a significant decrease in the mean Ki-67 index in the <b>LV</b> transduced vessels when compared to <b>C</b> at day 7 (P<0.01). …”

Dietary TU-100 decreases apoptosis induced by anti-CD3 antibody. by Nobuhiro Ueno (346397)

Mitochondrial function decreases in pasture-fed dairy cows during early lactation. by Mercedes García-Roche (6459200)

Thimerosal decreases the expression of survivin via the PI3K/Akt pathway. by Wen-Xue Li (189757)